The present invention provides for a pharmaceutical composition comprising {HEAD ~ a therapeutically effect amount} of {TAIL ~ an isolated peptide} having an amino acid sequence corresponding to the amino acid sequence of a V domain of RAGE and a pharmaceutically acceptable carrier 
of
The present invention provides for a pharmaceutical composition comprising { HEAD ~ a therapeutically effect amount } of { TAIL ~ an isolated peptide } having an amino acid sequence corresponding to the amino acid sequence of a V domain of RAGE and a pharmaceutically acceptable carrier
OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD HEAD REL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH